Center for Scientific Review; Notice of Closed Meetings
Published Date: 2/9/2026
Notice
Summary
The NIH’s Center for Scientific Review is holding two important virtual meetings on February 24, 2026, to review grant applications that help fund health research and innovations. These meetings were delayed by a 43-day government shutdown, so they’re happening quickly now to keep vital research on track. Scientists and small businesses applying for grants are the ones affected, with no direct money changes but a big impact on funding decisions.
Analyzed Economic Effects
2 provisions identified: 1 benefits, 0 costs, 1 mixed.
NIH grant reviews rescheduled after shutdown
If you applied for NIH research or small business grants, reviewers will evaluate applications virtually on February 24, 2026 after a 43-day government shutdown canceled earlier meetings. There is no direct change to grant amounts in this notice, but these urgent reviews affect whether your application is recommended for funding because evaluations must be sent to national advisory councils for timely funding recommendations.
Grant review meetings closed to protect secrets
The NIH stated the February 24, 2026 meetings will be closed to the public under 5 U.S.C. 552b(c)(4) and 552b(c)(6) because grant applications could disclose confidential trade secrets or personal information. That means you cannot attend these sessions and application details will be kept private to avoid revealing patentable material or personal information.
Your PRIA Score
Personalized for You
How does this regulation affect your finances?
Sign up for a PRIA Policy Scan to see your personalized alignment score for this federal register document and every other regulation we track. We analyze your financial profile against policy provisions to show you exactly what matters to your wallet.
Key Dates
Department and Agencies
Related Federal Register Documents
2026-06501 — Government-Owned Inventions; Availability for Licensing
The National Institutes of Health is offering a cool new invention—special human antibodies that can fight certain cancers and autoimmune diseases—for companies to license and develop into treatments. This means businesses can jump on this opportunity to create powerful new medicines using government-backed research. Interested parties should act soon and may need to sign agreements to get full details.
2026-06283 — Prospective Grant of an Exclusive Patent License: Pigment Epithelium-Derived Factor (PEDF) Peptides and Use for Treating Retinal Degeneration
The National Eye Institute plans to give Perpetual Biosciences, Inc. an exclusive license to use special PEDF peptides to treat eye diseases that cause vision loss. This means the company will have the sole right to develop and sell this promising treatment, potentially helping millions with retinal degeneration. If you want to comment or apply for a license, act fast—submissions close April 16, 2026!
2026-05957 — Center for Scientific Review; Notice of Closed Meetings
The NIH’s Center for Scientific Review is holding several closed virtual meetings in April 2026 to review and decide on important research grant applications. These meetings affect scientists seeking funding in areas like neuroscience, cancer, and liver disease. No public access is allowed to protect private info and trade secrets, and these reviews help decide where millions in research money will go.
2026-05672 — National Institute on Deafness and Other Communication Disorders; Notice of Closed Meetings
The National Institute on Deafness and Other Communication Disorders is holding two closed meetings in late April and early May 2026 to review grant applications and evaluate researchers’ qualifications. These meetings affect scientists seeking funding and help ensure top-notch research gets supported. No public access means privacy is protected, and the process keeps the money flowing to the best projects on time.
2026-05673 — Center for Scientific Review; Notice of Closed Meetings
The Center for Scientific Review is holding several closed virtual meetings on April 17, 2026, to review and evaluate important grant applications in health and science fields. These meetings protect private info and trade secrets while deciding who gets funding. Researchers and organizations applying for grants should note these dates as they impact funding decisions but don’t involve public attendance or extra costs.
2026-05738 — Submission for OMB Review; 30-Day Comment Request; National Institutes of Health (NIH) Loan Repayment Programs, (Office of the Director)
The NIH is asking for a 30-day public comment on extending its Loan Repayment Programs that help doctors and scientists pay off their student loans while they do important health research. This extension keeps the program running smoothly with no big changes, and comments are due by April 23, 2026. If you’re a researcher with student loans, this program could save you money while you help improve health!
Previous / Next Documents
Previous: 2026-02500 — Silicon Metal From Norway: Preliminary Affirmative Determination of Sales at Less Than Fair Value, Postponement of Final Determination, and Extension of Provisional Measures
The U.S. Department of Commerce says silicon metal from Norway is probably being sold in the U.S. for less than it should be, which could mean extra import fees soon. This affects companies importing this metal and might change prices or costs starting from early 2026. The final decision is delayed, giving everyone more time to weigh in before any money changes happen.
Next: 2026-02503 — NHTSA Automated Vehicle Safety Public Meeting: March 2026
On March 10, 2026, NHTSA is hosting a live meeting in Washington, DC, to talk about the future of self-driving cars. They want input from car makers, safety experts, and the public to help shape new safety rules and guidance. If you’re interested, register by March 5 and share your thoughts by April 10—this could impact how automated vehicles roll out safely in the U.S.
Take It Personal
Get Your Personalized Policy View
Start a Free Government Policy Watch to see how policy affects your household, then upgrade to PRIA Full Coverage for year-round monitoring.
Already have an account? Sign in